257 related articles for article (PubMed ID: 33215253)
1. Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.
Takheaw N; Sittithumcharee G; Kariya R; Kasinrerk W; Okada S
Cancer Immunol Immunother; 2021 Jun; 70(6):1557-1567. PubMed ID: 33215253
[TBL] [Abstract][Full Text] [Related]
2. Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.
Barth MJ; Mavis C; Czuczman MS; Hernandez-Ilizaliturri FJ
Clin Cancer Res; 2015 Oct; 21(19):4391-7. PubMed ID: 25964296
[TBL] [Abstract][Full Text] [Related]
3. Triggering of CD99 on monocytes by a specific monoclonal antibody regulates T cell activation.
Laopajon W; Pata S; Takheaw N; Surinkaew S; Khummuang S; Kasinrerk W
Cell Immunol; 2019 Jan; 335():51-58. PubMed ID: 30396687
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
[TBL] [Abstract][Full Text] [Related]
5. Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99/1 and MT99/2.
Khunkaewla P; Chiampanichayakul S; Yasamut U; Pata S; Kasinrerk W
Hybridoma (Larchmt); 2007 Aug; 26(4):241-50. PubMed ID: 17725386
[TBL] [Abstract][Full Text] [Related]
6. Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.
Bhatt S; Matthews J; Parvin S; Sarosiek KA; Zhao D; Jiang X; Isik E; Letai A; Lossos IS
Blood; 2015 Sep; 126(13):1555-64. PubMed ID: 26194763
[TBL] [Abstract][Full Text] [Related]
7. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Beltran E; Fresquet V; Martinez-Useros J; Richter-Larrea JA; Sagardoy A; Sesma I; Almada LL; Montes-Moreno S; Siebert R; Gesk S; Calasanz MJ; Malumbres R; Rieger M; Prosper F; Lossos IS; Piris MA; Fernandez-Zapico ME; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12461-6. PubMed ID: 21746927
[TBL] [Abstract][Full Text] [Related]
8. P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines.
Shirsath NP; Manohar SM; Joshi KS
Mol Cancer; 2012 Oct; 11():77. PubMed ID: 23075291
[TBL] [Abstract][Full Text] [Related]
9. Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy.
Zhou K; Hong H; Lin H; Gong L; Li D; Shi J; Zhou Z; Xu F; Wu Z
J Med Chem; 2022 Jan; 65(1):323-332. PubMed ID: 34962121
[TBL] [Abstract][Full Text] [Related]
10. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.
Lepelletier Y; Camara-Clayette V; Jin H; Hermant A; Coulon S; Dussiot M; Arcos-Fajardo M; Baude C; Canionni D; Delarue R; Brousse N; Benaroch P; Benhamou M; Ribrag V; Monteiro RC; Moura IC; Hermine O
Cancer Res; 2007 Feb; 67(3):1145-54. PubMed ID: 17283149
[TBL] [Abstract][Full Text] [Related]
11. CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
Kagiyama Y; Fujita S; Shima Y; Yamagata K; Katsumoto T; Nakagawa M; Honma D; Adachi N; Araki K; Kato A; Inaki K; Ono Y; Fukuhara S; Kobayashi Y; Tobinai K; Kitabayashi I
Cancer Sci; 2021 Jun; 112(6):2314-2324. PubMed ID: 33792119
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia.
Takheaw N; Kotemul K; Chaiwut R; Pata S; Laopajon W; Rangnoi K; Yamabhai M; Kasinrerk W
Antibodies (Basel); 2024 May; 13(2):. PubMed ID: 38804310
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
14. Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.
Loisel S; André PA; Golay J; Buchegger F; Kadouche J; Cérutti M; Bologna L; Kosinski M; Viertl D; Delaloye AB; Berthou C; Mach JP; Boumsell L
Mol Cancer; 2011 Apr; 10():42. PubMed ID: 21504579
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.
Gupta P; Goldenberg DM; Rossi EA; Cardillo TM; Byrd JC; Muthusamy N; Furman RR; Chang CH
Blood; 2012 Apr; 119(16):3767-78. PubMed ID: 22271448
[TBL] [Abstract][Full Text] [Related]
16. CD99 monoclonal antibody induce homotypic adhesion of Jurkat cells through protein tyrosine kinase and protein kinase C-dependent pathway.
Kasinrerk W; Tokrasinwit N; Moonsom S; Stockinger H
Immunol Lett; 2000 Jan; 71(1):33-41. PubMed ID: 10709783
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo.
Zhang L; Qian Z; Cai Z; Sun L; Wang H; Bartlett JB; Yi Q; Wang M
Am J Hematol; 2009 Sep; 84(9):553-9. PubMed ID: 19565649
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia.
Vaikari VP; Park M; Keossayan L; MacKay JA; Alachkar H
Nanomedicine; 2020 Oct; 29():102236. PubMed ID: 32535112
[TBL] [Abstract][Full Text] [Related]
19. Activity of thalidomide and lenalidomide in mantle cell lymphoma.
Richardson SJ; Eve HE; Copplestone JA; Dyer MJ; Rule SA
Acta Haematol; 2010; 123(1):21-9. PubMed ID: 19907157
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-based therapy for mantle cell lymphoma.
Munger CM; Vose JM; Joshi SS
Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
